Related Experiment Video
Updated: Mar 26, 2026

Optogenetic Phase Transition of TDP-43 in Spinal Motor Neurons of Zebrafish Larvae
Published on: February 25, 2022
Oxysterol-binding protein ORP3 rescues the Amyotrophic Lateral Sclerosis-linked mutant VAPB phenotype
Angie Darbyson1, Johnny K Ngsee1
1Ottawa Hospital Research Institute Department of Cellular and Molecular Medicine, University of Ottawa, 451 Smyth Road, Ottawa, Ontario, Canada K1H 8M5.
Abstract:
A mutation in VAPB causes a familial form of Amyotrophic Lateral Sclerosis. The mutant protein (VAPB-P56S) is aggregate prone and blocks retrograde traffic from the endoplasmic reticulum (ER) Golgi intermediate compartment (ERGIC) including trafficking to the nuclear envelope (NE). Here we report a morphological screen where overexpression of oxysterol binding protein-related protein-3 (ORP3) rescued the mutant VAPB phenotype. It resolved the mutant VAPB-induced membrane expansions, restored solubility of the mutant protein in non-ionic detergent, and restored trafficking of Emerin to the NE. Knockdown of ORP3 or VAPB increased the intracellular level of phosphatidylinositol 4-phosphate (PtdIns4P). Decreasing PtdIns4P levels by inhibiting its synthesis reduced the severity of the mutant VAPB-induced membrane expansions and restored Emerin trafficking to the NE. Thus, VAPB and its interacting partners cooperatively regulate protein trafficking through the ERGIC by modulating PtdIns4P levels.
Insights
Oxysterol binding protein-related protein-3 (ORP3) can rescue a familial form of Amyotrophic Lateral Sclerosis (ALS) caused by mutant VAPB. ORP3 and phosphatidylinositol 4-phosphate (PtdIns4P) levels regulate protein trafficking.
Area of Science:
- Cell Biology
- Neuroscience
- Molecular Biology
Background:
- A mutation in VAMP-associated protein B (VAPB) causes familial Amyotrophic Lateral Sclerosis (ALS).
- Mutant VAPB (VAPB-P56S) forms aggregates and disrupts retrograde protein transport from the endoplasmic reticulum-Golgi intermediate compartment (ERGIC) to the nuclear envelope (NE).
Purpose of the Study:
- To identify factors that rescue the cellular defects caused by mutant VAPB.
- To elucidate the role of VAPB and its interacting partners in protein trafficking regulation.
Main Methods:
- Morphological screening of genetic modifiers.
- Assessing protein solubility and subcellular localization.
- Investigating the role of phosphatidylinositol 4-phosphate (PtdIns4P) in VAPB-related cellular dysfunction.
Main Results:
- Overexpression of oxysterol binding protein-related protein-3 (ORP3) rescued VAPB-P56S-induced membrane expansions and restored Emerin trafficking to the NE.
- ORP3 overexpression restored the solubility of VAPB-P56S.
- Knockdown of ORP3 or VAPB increased intracellular PtdIns4P levels, and decreasing PtdIns4P ameliorated VAPB-P56S phenotypes.
Conclusions:
- VAPB and interacting proteins, like ORP3, regulate protein trafficking via the ERGIC.
- Modulation of PtdIns4P levels is a key mechanism in VAPB-mediated protein transport.
- ORP3 is a potential therapeutic target for VAPB-related ALS.
Related Concept Videos
The Unfolded Protein Response
Export of Misfolded Proteins out of the ER
Regulation of the Unfolded Protein Response
Rab Proteins
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Gene Families
Occasionally these regions can be adapted to take on new roles within the organism, becoming novel genes...

